1. Home
  2. UCAR vs TNON Comparison

UCAR vs TNON Comparison

Compare UCAR & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$1.74

Market Cap

9.2M

ML Signal

HOLD

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$1.14

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCAR
TNON
Founded
2013
2012
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.9M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
UCAR
TNON
Price
$1.74
$1.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$3.00
AVG Volume (30 Days)
22.4K
107.4K
Earning Date
10-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,816,075.00
$3,233,000.00
Revenue This Year
N/A
$19.56
Revenue Next Year
N/A
$71.06
P/E Ratio
N/A
N/A
Revenue Growth
57.22
N/A
52 Week Low
$1.71
$0.85
52 Week High
$9.43
$5.85

Technical Indicators

Market Signals
Indicator
UCAR
TNON
Relative Strength Index (RSI) 39.34 51.19
Support Level $1.71 $1.11
Resistance Level $1.91 $1.15
Average True Range (ATR) 0.10 0.04
MACD -0.01 0.01
Stochastic Oscillator 33.96 81.82

Price Performance

Historical Comparison
UCAR
TNON

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Share on Social Networks: